Fritextsökning
Innehållstyper
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Nya toppar på KD
Karolinska Development uppdaterar styrelsen.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Pledpharma fortsätter fas II-studie
Får klartecken att sätta igång del två i studieprogrammet Pliant.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Nya läkemedel ökar i USA
Under 2012 godkände FDA rekordmånga nya medicinska behandlingar. Bland annat godkändes Johnson and Johnsons Sirturo, som är den första nya TBC-behandlingen på många år.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Biopharma banar väg för nytt analysföretag
Grundarna till nystartade CRO-bolaget Solve Research and Consultancy fick sin affärsidé när fler och fler företag visade intresse för deras analysmetod Field-fl...
-
Platform for high security virus purification
Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a ...
-
Bekämpar Zika med öppna data
33 organisationer och tidskrifter åtar sig att se till att ny information om Zikaviruset delas så snabbt och öppet som möjligt.
-
Nanologica knoppar av fetmaforskning
Bildar nytt bolag som ska fokusera helt på läkemedelsprojekt för sjukdomar relaterade till fetma. Det nya bolaget tar med sig affärsutvecklingschefen som blir vd.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
KI i open innovation-samarbete
Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Miljonavtal för stamcellsforskning
Capricor Therapeutics och Janssen Biotech samarbetar i studie för att bota hjärtsjukdom.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
75 million for research schools
Gothenburg University, Karolinska Institutet, Linköping University and Umeå University have received SEK 75 million from the Research Council. The money will be...